Real-time enrollment status for this prader-willi syndrome clinical trial
Current Status
Suspended
Checked: April 17, 2026 at 5:09 AM UTC
| NCT Number | NCT06828861 |
| Recruiting Status | Suspended |
| Condition | Prader-Willi Syndrome |
| Phase | Clinical Trial |
| Target Enrollment | 90 participants |
| Active Locations | 17 sites in the US |
| Sponsor | Aardvark Therapeutics, Inc. |
| Last Updated on CT.gov | April 9, 2026 (1 week ago) |
As of April 17, 2026: Clinical trial NCT06828861 is currently suspended participants. This clinical trial study for prader-willi syndrome is not currently accepting new participants at 17 locations across the United States. The study is sponsored by Aardvark Therapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06828861 is currently suspended. The study may resume recruiting in the future.
This trial is recruiting at 17 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06828861 was last updated 1 week ago (April 9, 2026). HelloStudys verifies this status automatically.